This section of our website contains important information about our current forward-looking statements. Please also see our annual reports on Form 10-K and quarterly reports on Form 10-Q that we file with the SEC and that you can find on our website by clicking here. Information about prior forward-looking statements is included in the relevant communications document.
Our public communications and other reports may contain “forward-looking statements”—that is, statements related to future events. With respect to forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements often address our expected future business, financial performance, financial condition and results of operations, and often contain words such as “intends,” “estimates,” “anticipates,” “hopes,” “projects,” “plans,” “expects,” “drives,” “seek,” “believes,” “see,” “focus,” “should,” “will,” “would,” “opportunity,” “outlook,” “could,” “can,” “may,” “future,” “predicts,” “target,” “potential,” and similar expressions and the negative versions of these words, and may be identified by the context in which they are used. Such statements are based only upon current expectations of AtriCure. Any forward-looking statement speaks only as of the date made. Reliance should not be placed on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements include statements that address activities, events, circumstances or developments that AtriCure expects, believes or anticipates will or may occur in the future, such as earnings estimates (including projections and guidance), other predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure’s products. Forward-looking statements are based on AtriCure’s experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure’s control.
These risks and uncertainties include, but are not limited to, the following: our estimate of the market for our products in the U.S. and globally; the rate and degree of market acceptance of our products; negative clinical data, or impacts from trials which do not satisfy requirements of regulatory authorities; our ability to manage our intellectual property rights to provide meaningful protection; our ability to train, retain, and attract employees; an impairment to our goodwill; our ability to promptly train physicians in the use of our products; our reliance on independent distributors to sell our products; inventory-related charges; the timing of and ability to obtain and maintain regulatory clearances and approvals for our products; impacts of rising healthcare costs; the timing of and ability to obtain third party payor reimbursement of procedures utilizing our products; our ability to continue to be in compliance with applicable U.S. federal and state and foreign government laws and regulations; unfavorable publicity, or allegations of wrongdoing; credit risk from accounts receivable; our inability to comply with covenants of our credit facility; our ability to consummate acquisitions or, if consummated, to successfully integrate acquired businesses into our operations; failure of an acquisition or acquired company to achieve our plans and objectives generally; risk that proposed or consummated acquisitions may disrupt operations or pose difficulties in employee retention or otherwise affect financial or operating results; disruptions to our manufacturing operations; our failure to properly manage growth; disruptions of critical information systems or material breaches in the security of our systems; insufficient insurance coverage to cover our indemnification obligations and other liabilities; our ability to raise the capital that may be required to accomplish the foregoing; competition from existing and new products and procedures, including the development of drug or catheter-based technologies; fluctuation of quarterly financial results; fluctuations in exchange rates for future sales denominated in foreign currency, which represent a majority of our sales outside of the United States; reliance on third party manufacturers and suppliers; litigation, administrative or other proceedings which could result in fines, injunctions, or other penalties, government regulation including tax law changes; increases in income tax expense or other changes in tax expenses; stock price volatility; sales of material amounts of common stock; securities analysts discontinuing coverage for our common stock or issuing negative reports; our future ability to obtain additional FDA clearances or approvals for our products; our ability to comply with extensive FDA regulations; anti-takeover provisions in our organizational documents and applicable law; and the other risk factors AtriCure describes from time to time in SEC filings. There may be additional risks of which we are not presently aware or that we currently believe are immaterial which could have an adverse impact on our business.
You are cautioned to not place undue reliance on these forward-looking statements. AtriCure does not guarantee any forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
Our public communications and other reports may contain forward-looking projected financial information that is based on current estimates and forecasts. Actual results could differ materially.